Market research
87A.F American Renal Associates Holdings, Inc
F EUR Healthcare
Latest close
Latest stored close unavailable
Test a moving-average rule with historical data.
Market facts
- Market cap
- 328M
- P/E ratio
- Not available
- Analyst target
- Not available
- Dividend yield
- 13.%
- Beta
- 1.11
Profile
Instrument facts
- Exchange
- F
- Currency
- EUR
- Sector
- Healthcare
- Industry
- Health Information Services
- ISIN
- Not available
- Market cap
- 328M
- P/E ratio
- Not available
- Analyst target
- Not available
- Dividend yield
- 13.%
- Beta
- 1.11
About
About American Renal Associates Holdings, Inc
Spotlite360 Technologies, Inc. operates as a software as a service (SaaS) company. It offers Spotlite360, a SaaS-based supply chain execution, tracing, tracking, and sustainability platform to enterprise customers in the pharmaceutical, healthcare, and agricultural industries. The company was incorporated in 2014 and is headquartered in Vancouver, Canada.
Research context
American Renal Associates Holdings, Inc appears in PyInvesting’s Frankfurt Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- EUR
- Sector
- Healthcare
- Industry
- Health Information Services
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
Community
Investor discussion
1 comment
Sign in to join the 87A.F discussion.
5 years, 7 months ago
American Renal Associates Holdings, Inc is currently in a long term uptrend where the price is trading 22.9% above its 200 day moving average.
From a valuation standpoint, the stock is 100.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.5.
American Renal Associates Holdings, Inc's total revenue sank by 0.8% to $210M since the same quarter in the previous year.
Its net income has dropped by 156.3% to $-3M since the same quarter in the previous year.
Finally, its free cash flow fell by 34.7% to $15M since the same quarter in the previous year.
Based on the above factors, American Renal Associates Holdings, Inc gets an overall score of 2/5.